about
Amineptin dependence. Detection of patients at risk. Report of 8 casesBradycardia during citalopram treatment: a case reportTelemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE project[Relations between mood disorders and personality. Recent data]Clinical state assessment in bipolar patients by means of HRV features obtained with a sensorized T-shirt.A theoretical reappraisal of mixed states: dysphoria as a third dimension.Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects.Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.Tricyclic antidepressant plasma levels after fluoxetine addition.Neural correlates of generation and inhibition of verbal association patterns in mood disordersPossible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years.Dispositional Mindfulness and Subjective Time in Healthy Individuals.Phenomenology of racing and crowded thoughts in mood disorders: a theoretical reappraisal.A three-dimensional model of thoughts: insight into depression.Time course of response to paroxetine: influence of plasma level.Alterations in neural systems mediating cognitive flexibility and inhibition in mood disorders.Can home-monitoring of sleep predict depressive episodes in bipolar patients?Methadone maintenance treatment: an update.Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.[Yawning and sexual excitation under clomipramine. Role of serotoninergic mechanisms. Apropos of 2 cases][Mixed depression and DSM-5: A critical review].Long-term treatment of depression: is there a use for depot antidepressants?The lactate provocation test to investigate the relationships between panic attacks and psychosis: a report of two cases.[Psychiatry]Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation.Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: a case report.Early telephone intervention for psychiatric outpatients starting antidepressant treatment.Mania resulting from continuous positive airways pressure in a depressed man with sleep apnea syndrome.Nefazodone may inhibit the metabolism of carbamazepine: three case reports.The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients.Neural substrates of rumination tendency in non-depressed individuals.Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results.Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.[Comparative study of two techniques for the determination of amitriptyline and nortriptyline: EMIT and gas chromatography]Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic response.Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation.Lithium augmentation in venlafaxine non-responders: an open study.
P50
Q28267833-61DD76F5-1E38-407D-8981-67EEA4DE9A9FQ28371182-9EFC00A7-E36C-429F-98DA-6E9CCD836568Q30434498-CF42E285-B3A2-406B-84F5-38D38827032AQ31028351-F4659D68-CECB-4B63-B157-2B2F2239469DQ33443708-A6AB0F9B-242E-4433-96D3-F3BAAF8DB31DQ34185311-9863E993-AB3E-4930-B8E2-3544D810D21DQ34363996-BD72F539-7927-4C00-98D4-7F806C9FF53AQ34508037-A2722D42-3DB8-46ED-8AA3-B0F863C4B244Q34510284-C9F1BCBB-222F-4BD4-A6BB-EBAEFD6953F9Q35555415-923DDF40-C0F4-472C-BC1F-0251FDB7031BQ35790487-136C9019-7A8E-4BFE-8604-042D17341E7CQ35956644-EF3867C1-B9BE-4CF0-A4C9-51F3E722B2EEQ36626047-59986A91-884C-47DD-BD8D-1160335057EAQ36948666-B4C93D32-4FA9-4260-834D-3AAB8A7CD315Q37514543-B958BBBE-F127-43C7-B4E6-4F624B81833DQ38013011-E7E9E6CB-A802-493D-8C34-AC589A8E8A29Q39337612-85EBA0BD-5201-439E-A151-8683E74AFDF9Q40086202-BDCDF733-E608-45F3-A60E-6419A05BBA88Q40138803-C351934D-8477-4EFD-A077-1DFAFC11C038Q40470835-7B8C942D-1D1D-4874-A0E6-6ED02B80A9EAQ40478715-0D24EA95-75D1-4BAD-A018-6753233733B5Q41150058-90778B89-FCAB-4817-9F9E-38F7D606CA79Q41213158-EC239D9A-3C85-4328-A5BC-1520F7FD5FDFQ41528260-E2AEB702-6A78-4461-9797-BDB2F97B6BF6Q42167461-71DE5366-430D-44BC-909F-18FEDDF61B04Q42167642-13A47D70-3ECB-4B90-96FF-BBC62ADDCF7FQ42551679-5A99DA5F-8BC9-4CB6-9562-EAA9967EF2F1Q42557705-D527AE8F-2BC5-4E82-BB39-79CD57E6CCCAQ43157783-E07F3E61-B4DC-4B5E-9567-34706F22D1F5Q43565512-3748E423-D4D1-42C2-BA91-4F90C400D8DEQ43713759-91FEACCE-CF80-45C0-A465-A43FFBC922A5Q43976935-A3D003AC-0298-40A0-AD38-AFE8CF4EA117Q43979095-433711A9-8A11-41AA-AD70-CC99AFD77AF1Q44066970-4D307E2A-D77D-4211-BB91-8F18A8A379CCQ44107617-5C35822C-B2FC-4199-8E05-D2D6429CE90BQ44360024-85271242-98E2-48FF-8515-630C9DBF9962Q44383829-41A5871E-022E-4472-8BB1-F69DD910A0D4Q44396259-530E3D5C-DCD9-4456-8C23-EB8A74475CE8Q44607566-2F4D109F-0BE9-4985-AB35-24B8B5FE4812Q44651667-FA7958B3-A9DE-4899-BC2C-75B4C890954D
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Gilles Bertschy
@ast
Gilles Bertschy
@en
Gilles Bertschy
@es
Gilles Bertschy
@nl
Gilles Bertschy
@sl
type
label
Gilles Bertschy
@ast
Gilles Bertschy
@en
Gilles Bertschy
@es
Gilles Bertschy
@nl
Gilles Bertschy
@sl
prefLabel
Gilles Bertschy
@ast
Gilles Bertschy
@en
Gilles Bertschy
@es
Gilles Bertschy
@nl
Gilles Bertschy
@sl
P214
P1053
A-4349-2010
P106
P21
P214
P31
P3829
P496
0000-0002-0827-7659
P734
P735
P7859
viaf-54229020